(Q39784389)

14 September 2017

1 reference

title

The role of serine proteases in the blood coagulation cascade (English)

1 reference

14 September 2017

The Role of Serine Proteases in the Blood Coagulation Cascade (English)

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

9 April 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367103

9 April 2023

author name string

E. W. Davie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367103

9 April 2023

K. Fujikawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367103

9 April 2023

K. Kurachi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367103

9 April 2023

W. Kisiel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367103

9 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=367103

9 April 2023

publication date

1 January 1979

1 reference

full work available at URL

14 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9780470122938.ch6

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

https://onlinelibrary.wiley.com/doi/full/10.1002/9780470122938.ch6

9 April 2023

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Advances in Enzymology and Related Areas of Molecular Biology

9 April 2023

published in

1 reference

14 September 2017

volume

48

1 reference

14 September 2017

page(s)

277-318

1 reference

Human thrombin: partial primary structure

14 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Bovine factor X1 (Stuart factor). Primary structure of the light chain

9 April 2023

4

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Bovine factor X1 (Stuart factor): amino-acid sequence of heavey chain

9 April 2023

5

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Amino acid sequence studies on the alpha chain of human fibrinogen. Characterization of 11 cyanogen bromide fragments

9 April 2023

8

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Amino acid sequence studies on the α chain of human fibrinogen. Covalent structure of the α-chain portion of fragment D

9 April 2023

9

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Amino acid sequence studies on the alpha chain of human fibrinogen. Isolation and characterization of two linked alpha-chained cyanogen bromide fragments from fully cross-linked fibrin

9 April 2023

10

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Vitamin K-Dependent Formation of γ-Carboxyglutamic Acid

9 April 2023

14

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Prekallikrein deficiency in man

9 April 2023

15

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil

9 April 2023

16

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Flaujeac trait. Deficiency of human plasma kininogen

9 April 2023

17

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Identity of contact activation cofactor and Fitzgerald factor

9 April 2023

19

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Urinary and kidney cell plasminogen activator (urokinase)

9 April 2023

22

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

22 Plasminogen and plasmin

9 April 2023

23

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

23 Rabbit plasminogen and plasmin isozymes

9 April 2023

24

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma

9 April 2023

25

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition

9 April 2023

26

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Hageman trait and PTA deficiency; the role of contact of blood with glass

9 April 2023

27

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Surface activation of plasma clotting: a function of Hageman factor

9 April 2023

29

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Characterization of bovine factor XIIa (activated Hageman factor)

9 April 2023

30

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation

9 April 2023

33

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Defective Activation of Clotting, Fibrinolytic, and Permeability-Enhancing Systems in Human Fletcher Trait Plasma

9 April 2023

34

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The mode of action of Hageman factor in the release of plasma kinin

9 April 2023

37

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Partial purification of bovine plasma kallikreinogen, its activation by the Hageman factor

9 April 2023

38

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin

9 April 2023

41

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Bovine prekallikrein activator with functional activity as Hageman factor

9 April 2023

45

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Plasma prekallikrein: isolation, characterization, and mechanism of activation

9 April 2023

46

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Isolation and characterization of a prealbumin activator of prekallikrein from acetone-activated human plasma

9 April 2023

49

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein

9 April 2023

50

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Structural changes accompanying enzymatic activation of human Hageman factor

9 April 2023

51

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor

9 April 2023

54

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein

9 April 2023

55

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Preparation, characterization, and activation of a highly purified factor XI: evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII

9 April 2023

56

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Partial purification and characterization of contact activation cofactor

9 April 2023

57

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Isolation and characterization of bovine factor XII (Hageman factor).

9 April 2023

58

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement

9 April 2023

61

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).

9 April 2023

62

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Purification of factor XII (Hageman factor) from human plasma

9 April 2023

64

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Human factor XII (Hageman factor)

9 April 2023

65

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule

9 April 2023

66

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen

9 April 2023

67

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent

9 April 2023

68

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor)

9 April 2023

70

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of the human intrinsic blood coagulation system

9 April 2023

72

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor)

9 April 2023

74

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator

9 April 2023

75

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Hageman factor, a novel sialoglycoprotein with esterase activity

9 April 2023

76

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Journal of Clinical Investigation

9 April 2023

79

50

100

Wuepper

1972

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The inhibition of human plasma Kallikrein by antithrombin III

9 April 2023

81

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Inhibition of purified plasma Kallikrein by antithrombin III and heparin

9 April 2023

82

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Anticoagulant Action of Heparin

9 April 2023

83

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Inhibition of bovine factor IXa and factor Xa.beta. by antithrombin III

9 April 2023

85

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Formation of a serine enzyme in the presence of bovine factor VIII (antihemophilic factor) and thrombin

9 April 2023

86

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Binding of thrombin to antithrombin III

9 April 2023

88

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Inhibition of the activated Cls subunit of the first component of complement by antithrombin III in the presence of heparin

9 April 2023

91

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation

9 April 2023

93

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Interrelations Between Different Mechanisms of Release of Biologically Active Peptides from Blood Plasma

9 April 2023

94

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Role of Hageman Factor in the Activation of Vasodilator Activity in Human Plasma

9 April 2023

95

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The nature of the kallidins released from human plasma by kallikreins and other enzymes

9 April 2023

97

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein

9 April 2023

99

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The isolation of human plasma prekallikrein

9 April 2023

100

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins

9 April 2023

101

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Conversion of bovine prekallikrein to kallikrein. Evidence of limited proteolysis of prekallikrein by bovine hageman factor (factor XII)

9 April 2023

103

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Investigation of serum trypsin and related substances. I. The quantitative demonstration of trypsinlike activity in human blood serum by a micromethod

9 April 2023

108

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein

9 April 2023

109

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein

9 April 2023

110

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein

9 April 2023

112

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Inhibitors of kallikrein in human plasma

9 April 2023

113

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Human plasma kallikrein. Purification and preliminary characterization

9 April 2023

114

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor.

9 April 2023

115

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Isolation and characterization of bovine factor XI (plasma thromboplastin antecedent)

9 April 2023

117

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Active site of bovine factor XI (plasma thromboplastin antecedent)

9 April 2023

118

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa(activated plasma thromboplastin antecedent)

9 April 2023

122

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

THE REACTION BETWEEN ACTIVATED PLASMA THROMBOPLASTIN ANTECEDENT AND DIISOPROPYLPHOSPHOFLUORIDATE

9 April 2023

123

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin

9 April 2023

124

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Partial purification of factors XI and XIa: a comparison of their molecular size and structure

9 April 2023

126

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin

9 April 2023

128

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Identification of gamma-carboxyglutamic acid residues in bovine factors IX and X, and in a new vitamin K-dependent protein

9 April 2023

130

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Primary structure of the vitamin K-dependent part of prothrombin

9 April 2023

131

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S

9 April 2023

134

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Activation of factor IX by activated factor X: A link between the extrinsic and intrinsic coagulation systems

9 April 2023

136

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

9 April 2023

Hirudin

138

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII

9 April 2023

141

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content

9 April 2023

142

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Molecular structural studies of human factor VIII

9 April 2023

143

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Isolation, subunit structure, and proteolytic modification of bovine factor VIII

9 April 2023

144

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Sedimentation of plasma antihemophilic factor

9 April 2023

145

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Molecular Forms of Antihaemophilic Globulin in Plasma, Cryoprecipitate and after Thrombin Activation

9 April 2023

146

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Factor VIII recombination after dissociation by CaCl12.

9 April 2023

149

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Plasma Aggregating Factor (Bovine) for Human Platelets: A Marker for Study of Antihemophilic and von Willebrand Factors

9 April 2023

150

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Evidence that bovine factor VIII, not bovine fibrinogen, aggregates human platelets

9 April 2023

151

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Separation of Bovine Factor VIII-Related Antigen (Platelet Aggregating Factor) from Bovine Antihemophilic Factor

9 April 2023

153

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Bovine factors X1and X 2 (Stuart factor). Isolation and characterization

9 April 2023

154

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Characterization of two glycoprotein variants of bovine factor X and demonstration that the factor X zymogen contains two polypeptide chains

9 April 2023

155

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Bovine factor X1 (Stuart factor). Mechanism of activation by a protein from Russell's viper venom

9 April 2023

156

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways

9 April 2023

157

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Activation of bovine factor X (Stuart factor): conversion of factor Xaalpha to factor Xabeta

9 April 2023

158

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The preparation of activated Factor X and its action on prothrombin

9 April 2023

159

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The activation of factor V by factor Xa or α-chymotrypsin and comparison with thrombin and RVV-V action. An improved factor V isolation procedure

9 April 2023

165

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

TAMe Esterase Activity of Blood Thrombokinase after Repeated Electrophoretic Fractionations

9 April 2023

166

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell's-viper venom

9 April 2023

167

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Bovine Factor X. II. Characterization of purified Factor X. Alterations in zone electrophoretic and chromatographic behavior occurring during purification

9 April 2023

168

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Action of human thrombokinase on human prothrombin and p-tosyl-l-arginine methyl ester

9 April 2023

169

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Purification and activation of human factor X: cooperative effect of Ca++ on the activation reaction

9 April 2023

171

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

THE ACTIVATION OF STUART FACTOR (FACTOR X) BY ACTIVATED ANTIHEMOPHILIC FACTOR (ACTIVATED FACTOR 8)

9 April 2023

172

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Bovine factor X 1a (activated Stuart factor). Evidence of homology with mammalian serine proteases

9 April 2023

174

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The Inhibition of Activated Factor X with Di:isopropyl Fluorophosphate

9 April 2023

176

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Prothrombin structure, activation, and biosynthesis

9 April 2023

178

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Mechanism of bovine prothrombin activation by an insoluble preparation of bovine factor X a (thrombokinase).

9 April 2023

180

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Proteolysis of human factor II by factor Xa in the presence of hirudin

9 April 2023

183

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Serum Ac-globulin; role in blood coagulation; partial purification; properties; and quantitative determination

9 April 2023

185

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Chromatographic purification of human serum accelerator globulin

9 April 2023

187

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

PURIFICATION AND PROPERTIES OF BOVINE FACTOR V: A CHANGE OF MOLECULAR SIZE DURING BLOOD COAGULATION.

9 April 2023

188

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

THROMBIN AND THE INTERACTION OF FACTORS 8 AND 9.

9 April 2023

190

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Conversion of Fibrin to Desmofibrin

9 April 2023

191

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

ACTIVATION OF THE FIBRIN STABILIZING FACTOR OF PLASMA BY THROMBIN

9 April 2023

192

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

A peptide released from plasma fibrin stabilzing factor in the conversion to the active enzyme by thrombin

9 April 2023

194

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin

9 April 2023

195

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Inactivation of human thrombin in the presence of human α1-proteinase inhibitor

9 April 2023

201

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The inhibition of thrombin by diisopropyl phosphorofluoridate

9 April 2023

204

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Comparative Studies on the Inhibition of Trypsin, Plasmin, and Thrombin by Derivatives of Benzylamine and Benzamidine

9 April 2023

206

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Comparison of the esterase activities of trypsin, plasmin, and thrombin on guanidinobenzoate esters. Titration of the enzymes

9 April 2023

207

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Isolation and characterization of bovine factor VII

9 April 2023

209

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Role of a Buried Acid Group in the Mechanism of Action of Chymotrypsin

9 April 2023

211

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Structure of crystalline alpha-chymotrypsin. IV. The structure of indoleacryloyl-alpha-chyotrypsin and its relevance to the hydrolytic mechanism of the enzyme

9 April 2023

212

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Subtilisin. Stereochemical mechanism involving transition-state stabilization

9 April 2023

213

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Serine Proteases: Structure and Mechanism of Catalysis

9 April 2023

215

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

The Crystal and Molecular Structure of DIP-inhibited Bovine Trypsin at 2.7A Resolution

9 April 2023

216

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region

9 April 2023

218

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Mode of action of soybean trypsin inhibitor (Kunitz) as a model for specific protein-protein interactions.

9 April 2023

219

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Crystal structure of the complex of porcine trypsin with soybean trypsin inhibitor (Kunitz) at 2.6 Å resolution

9 April 2023

220

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Structure and specific binding of trypsin: comparison of inhibited derivatives and a model for substrate binding

9 April 2023

221

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

MODIFICATION OF A METHIONINE RESIDUE NEAR THE ACTIVE SITE OF CHYMOTRYPSIN BY P-NITROPHENYL BROMOACETYL-ALPHA-AMINOISOBUTYRATE

9 April 2023

222

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Structure of crystalline -chymotrypsin. II. A preliminary report including a hypothesis for the activation mechanism

9 April 2023

223

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

9 April 2023

227

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Activation of human factor IX (Christmas factor)

9 April 2023

228

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Activation of human factor X (Stuart factor) by a protease from Russell's viper venom

9 April 2023

229

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Bovine factor IX (christmas factor). Further evidence of homology with factor X (Stuart factor) and prothrombin

9 April 2023

230

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

TRYPSINOGEN AND CHYMOTRYPSINOGEN AS HOMOLOGOUS PROTEINS

9 April 2023

231

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Corrections to the amino acid sequence of bovine chymotrypsinogen A.

9 April 2023

232

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

Amino-acid Sequence of Porcine Pancreatic Elastase and its Homologies with other Serine Proteinases

9 April 2023

233

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

A comparison of bovine prothrombin, factor IX (Christmas factor), and factor X (Stuart factor).

9 April 2023

234

1 reference

https://api.crossref.org/works/10.1002/9780470122938.CH6

9 April 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=367103

9 April 2023

1 reference